Hangzhou Tigermed Consulting Co., Ltd. Class H (HK:3347)
:3347
3347 Analyst Ratings
Strong Buy
4 Buy
0 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
3347 Stock 12 Month Forecast
Average Price Target
HK$55.78
▲(3.29% Upside)
| Highest Price TargetHK$61.40 | Average Price TargetHK$55.78 | Lowest Price TargetHK$50.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Detailed List of Analyst Forecasts
Jefferies
HK$55
Buy
1.85%
Upside
Reiterated
03/31/26
Goldman Sachs
HK$61.4
Buy
13.70%
Upside
Reiterated
03/30/26
HSBC
HK$51.1→HK$54
Buy
0.00%
Upside
Reiterated
11/05/25
J.P. Morgan
HK$37→HK$38
Sell
-29.63%
Downside
Reiterated
10/29/25
Unknown Analyst
Bank of ChinaNot Ranked
Bank of China
HK$51
Buy
-5.56%
Downside
Reiterated
09/01/25
Unknown Analyst
CICCNot Ranked
CICC
HK$57.5
Buy
6.48%
Upside
Reiterated
08/29/25
Citi
HK$37→HK$73
Buy
35.19%
Upside
Reiterated
07/14/25
Unknown Analyst
Citic SecuritiesNot Ranked
Citic Securities
HK$50
Buy
-7.41%
Downside
Reiterated
07/04/25
Unknown Analyst
DaiwaNot Ranked
Daiwa
HK$38
Sell
-29.63%
Downside
Reiterated
06/12/25
Analyst Type
Any
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Jefferies
HK$55
Buy
1.85%
Upside
Reiterated
03/31/26
Goldman Sachs
HK$61.4
Buy
13.70%
Upside
Reiterated
03/30/26
HSBC
HK$51.1→HK$54
Buy
0.00%
Upside
Reiterated
11/05/25
J.P. Morgan
HK$37→HK$38
Sell
-29.63%
Downside
Reiterated
10/29/25
Unknown Analyst
Bank of ChinaNot Ranked
Bank of China
HK$51
Buy
-5.56%
Downside
Reiterated
09/01/25
Unknown Analyst
CICCNot Ranked
CICC
HK$57.5
Buy
6.48%
Upside
Reiterated
08/29/25
Citi
HK$37→HK$73
Buy
35.19%
Upside
Reiterated
07/14/25
Unknown Analyst
Citic SecuritiesNot Ranked
Citic Securities
HK$50
Buy
-7.41%
Downside
Reiterated
07/04/25
Unknown Analyst
DaiwaNot Ranked
Daiwa
HK$38
Sell
-29.63%
Downside
Reiterated
06/12/25
Best Analysts Covering Hangzhou Tigermed Consulting Co., Ltd. Class H
3 Months
xxx
Success Rate
2/2 ratings generated profit
Average Return
+27.50%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +27.50% per trade.
1 Year
2 Years
xxx
Success Rate
4/7 ratings generated profit
Average Return
+9.77%
reiterated a xxx
rating 5 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 57.14% of your transactions generating a profit, with an average return of +9.77% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
3347 Analyst Recommendation Trends
Rating
Oct 25
Nov 25
Jan 26
Mar 26
Apr 26
Strong Buy
11
9
7
7
6
Buy
0
0
0
0
0
Hold
41
53
39
23
16
Sell
2
1
1
0
0
Strong Sell
0
0
0
0
0
total
54
63
47
30
22
Each month's total comprises the sum of three months' worth of ratings.
3347 Financial Forecast
3347 Stock Forecast FAQ
What is HK:3347’s average 12-month price target, according to analysts?
Based on analyst ratings, Hangzhou Tigermed Consulting Co., Ltd. Class H’s 12-month average price target is 55.78.
What is HK:3347’s upside potential, based on the analysts’ average price target?
Hangzhou Tigermed Consulting Co., Ltd. Class H has 3.29% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Hangzhou Tigermed Consulting Co., Ltd. Class H a Buy, Sell or Hold?
Hangzhou Tigermed Consulting Co., Ltd. Class H has a consensus rating of Strong Buy, which is based on 4 buy ratings, 0 hold ratings and 0 sell ratings.
What is Hangzhou Tigermed Consulting Co., Ltd. Class H’s share price target?
The average share price target for Hangzhou Tigermed Consulting Co., Ltd. Class H is 55.78. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is HK$61.40 ,and the lowest forecast is HK$50.00. The average share price target represents 3.29% Increase from the current price of HK$54.
The highest analyst share price target is HK$61.40 ,and the lowest forecast is HK$50.00. The average share price target represents 3.29% Increase from the current price of HK$54.
What do analysts say about Hangzhou Tigermed Consulting Co., Ltd. Class H?
Hangzhou Tigermed Consulting Co., Ltd. Class H’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
How can I buy shares of Hangzhou Tigermed Consulting Co., Ltd. Class H?
To buy shares of HK:3347, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.